Toxin News and Research

RSS

Gut infection can lead to a pathology resembling Parkinson's disease

A new study by Montreal scientists published today in Nature demonstrates that a gut infection can lead to a pathology resembling Parkinson's disease in a mouse model lacking a gene linked to the human disease.

17 Jul 2019

New study uncovers 3D structure of toxin responsible for C. diff infection

A new study, led by researchers from the University of California, Irvine, uncovers the long-sought-after, three-dimensional structure of a toxin primarily responsible for devastating Clostridium difficile infection.

16 Jul 2019

Botulinum toxin may offer relief from chronic pelvic pain in women with endometriosis

Pelvic pain associated with endometriosis often becomes chronic and can persist (or recur) following surgical and hormonal interventions.

11 Jul 2019

Two New Resistance-Proof Antibiotics Have Been Created

Antibiotic resistance is a growing global concern. Two new resistance-proof antibiotics have been created at the Inserm and Université de Rennes 1.

11 Jul 2019

Study sheds light on complex caspase-1-induced cell death mechanisms

Most unnecessary or dangerous cells such as virus-infected cells commit suicide by activating an in-built suicide program.

5 Jul 2019

Study uncovers origin of cell mask that hides stomach cancer

A layer of cells that look like normal stomach lining on top of sites of stomach cancer can make it difficult to spot after removal of a Helicobacter pylori infection. In a recent study, researchers from Hiroshima University have uncovered the origin of this layer of cells: it is produced by the cancer tissue itself.

4 Jul 2019

Copper compound with potential as therapy for ALS shows further promise

A compound with potential as a treatment for ALS has gained further promise in a new study that showed it improved the condition of mice whose motor neurons had been damaged by an environmental toxin known to cause features of ALS.

2 Jul 2019

Protein Clumps In ALS Neurons Provide Potential Target For New Therapies

Amyotrophic lateral sclerosis is a neurological condition that affects motor neurons -- the nerve cells that control breathing and muscles.

2 Jul 2019

Research provides genomic warning flag just in time for beach season

An article published today in the Open Access journal GigaScience might make you squirm if you plan to hit the beach this summer. The article presents the draft genomes of three different jellyfish species.

30 Jun 2019

Scientists identify malaria's Achilles' heel

Scientists have finally found malaria's Achilles' heel, a neurotoxin that isn't harmful to any living thing except Anopheles mosquitoes that spread malaria.

29 Jun 2019

Researchers discover new neurotoxin that selectively targets mosquitoes

Researchers at the universities in Stockholm and Lund, in collaboration with researchers from the University of California, have found a new toxin that selectively targets mosquitos.

28 Jun 2019

Vitamin D metabolite may stop mechanism by which cancer cells become drug-resistant

What's good for our bones may also help stop cancer cells that develop resistance to multiple chemotherapy drugs.

14 Jun 2019

'Food for special medical purposes' can benefit patients with earliest stages of Alzheimer's disease

Study supports the hypothesis that a food for special medical purposes containing Fortasyn Connect can benefit patients with mild cognitive impairment who are at high risk of progression to the dementia stage of Alzheimer's disease, according to research published in the Journal of Alzheimer's Disease Reports.

13 Jun 2019

Tetrodotoxin found in pufferfish can provide potent pain relief when given properly

Opioids remain a mainstay of treatment for chronic and surgical pain, despite their side effects and risk for addiction and overdose.

13 Jun 2019

Drink containing multinutrient combination can benefit patients with mild cognitive impairment

Study supports the hypothesis that a food for special medical purposes containing Fortasyn Connect® can benefit patients with mild cognitive impairment who are at high risk of progression to the dementia stage of Alzheimer's disease, according to research published in the Journal of Alzheimer's Disease Reports

13 Jun 2019